We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Public Health

Public Health

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Significant Barriers and Pandemic Setbacks: Why Hepatitis B Birth Dose Coverage Remains Low in The Gambia
Infectious Diseaseshepatitis Bpublic health

Significant Barriers and Pandemic Setbacks: Why Hepatitis B Birth Dose Coverage Remains Low in The Gambia

By MedXY|Jan 29, 2026

A 7-year retrospective analysis in The Gambia reveals that despite early adoption, timely Hepatitis B birth dose coverage remains critically low at 6.4%, severely hindered by weekend births and the COVID-19 pandemic.

Beyond the Initial Surge: Critical Lessons for Clinical Mental Health Care from the COVID-19 Pandemic
newsCOVID-19health equity

Beyond the Initial Surge: Critical Lessons for Clinical Mental Health Care from the COVID-19 Pandemic

By MedXY|Jan 29, 2026

This article examines the Lancet Psychiatry Standing Commission’s findings on mental health care delivery during COVID-19, highlighting the disproportionate impact on vulnerable groups, the rise of Long COVID, and the urgent need for

Scalable Digital Support Reduces Distress in Caregivers of Depressed Patients: Results from a Large-Scale RCT
newsdepressiondigital health

Scalable Digital Support Reduces Distress in Caregivers of Depressed Patients: Results from a Large-Scale RCT

By MedXY|Jan 29, 2026

A large-scale randomized controlled trial reveals that online self-help programs, featuring either automated or individualized psychological support, significantly reduce the mental health burden on informal caregivers of people with depres

Mammography Screening and Mortality: A 40-Year European Population-Based Evaluation Shows Shift to Early-Stage Detection
newsbreast cancermammography

Mammography Screening and Mortality: A 40-Year European Population-Based Evaluation Shows Shift to Early-Stage Detection

By MedXY|Jan 28, 2026

A massive 21-country study confirms that mammography screening has significantly shifted breast cancer detection toward earlier stages, contributing to a substantial decline in mortality across Europe, though treatment advances also play a

Beyond the Initial Quit: Mobile Chat Messaging as a Scalable Solution for Smoking Relapse Prevention
Internal MedicinemHealthRelapse Prevention

Beyond the Initial Quit: Mobile Chat Messaging as a Scalable Solution for Smoking Relapse Prevention

By MedXY|Jan 26, 2026

Recent clinical trials demonstrate that mobile chat-based interventions, combining live counselors and chatbots, significantly reduce smoking relapse rates and improve long-term abstinence through personalized, real-time support and engagem

Air Pollution as a Dual Threat: Linking Environmental Exposure to Motor Neuron Disease Risk and Accelerated Progression
Neurologyair pollutionenvironmental health

Air Pollution as a Dual Threat: Linking Environmental Exposure to Motor Neuron Disease Risk and Accelerated Progression

By MedXY|Jan 26, 2026

A comprehensive Swedish study reveals that long-term exposure to particulate matter and nitrogen dioxide significantly increases the risk of Motor Neuron Disease and accelerates functional decline, even in regions with relatively low pollut

US Public Supports Licensing International Surgeons but Remains Hesitant to Receive Personal Care Without US Residency Training
General Surgerypatient safety

US Public Supports Licensing International Surgeons but Remains Hesitant to Receive Personal Care Without US Residency Training

By MedXY|Jan 25, 2026

A cross-sectional study reveals that while 85% of Americans support licensing internationally trained surgeons to address workforce shortages, nearly 80% are reluctant to personally undergo surgery by them, highlighting a significant gap be

High-Dose Influenza Vaccine Offers Superior Protection Against Hospitalization in Older Adults Regardless of Diabetes Status
Diabetes & EndocrinologyDiabetes Mellitusgeriatric medicine

High-Dose Influenza Vaccine Offers Superior Protection Against Hospitalization in Older Adults Regardless of Diabetes Status

By MedXY|Jan 25, 2026

A secondary analysis of the DANFLU-2 trial demonstrates that high-dose influenza vaccines significantly reduce cardiorespiratory and influenza-related hospitalizations in adults aged 65 and older, with consistent benefits observed in patien

Targeting the Right Brain: Structural Subtyping and Vascular Profiles Predict Response to Lifestyle Interventions in Dementia Prevention
Neurologydementia preventionlifestyle intervention

Targeting the Right Brain: Structural Subtyping and Vascular Profiles Predict Response to Lifestyle Interventions in Dementia Prevention

By MedXY|Jan 20, 2026

A sub-analysis of the FINGER trial reveals that individuals with specific grey matter patterns and lower vascular risk derive the most structural brain benefit from multimodal lifestyle interventions, highlighting the potential for personal

Sniffing Out Health: How a New Smartphone App Could Revolutionize Smell Testing
newsdigital healthMedical Screening

Sniffing Out Health: How a New Smartphone App Could Revolutionize Smell Testing

By MedXY|Jan 18, 2026

Researchers have developed a rapid, 5-item mobile application-based test to screen for olfactory dysfunction, offering a high-accuracy, low-cost alternative to traditional diagnostic methods for a condition often linked to aging and neurolo

Evidence-Based Evolution: How FDA Scientists Shielded Mifepristone Regulation From Political Interference
newsFDA regulationreproductive health

Evidence-Based Evolution: How FDA Scientists Shielded Mifepristone Regulation From Political Interference

By MedXY|Jan 17, 2026

A comprehensive review of over 5,000 FDA documents confirms that the agency’s regulation of mifepristone between 2011 and 2023 was driven by clinical safety data and internal scientific consensus, remaining remarkably resilient agains

Digital Storytelling Boosts Pediatric Influenza Vaccination Rates Despite Low Engagement: Insights from a Pilot Randomized Trial
newsdigital healthhealth equity

Digital Storytelling Boosts Pediatric Influenza Vaccination Rates Despite Low Engagement: Insights from a Pilot Randomized Trial

By MedXY|Jan 16, 2026

A pilot randomized clinical trial reveals that text-based digital stories centered on community voices significantly improved influenza vaccination rates among children in Black communities, even though only 7% of caregivers viewed the narr

Scalable Success: Electronic Patient-Managed Interventions Significantly Drive Benzodiazepine Cessation
newsBenzodiazepinesdeprescribing

Scalable Success: Electronic Patient-Managed Interventions Significantly Drive Benzodiazepine Cessation

By MedXY|Jan 16, 2026

The EMPOWER-ED randomized clinical trial demonstrates that an electronic, patient-centered intervention significantly increases the odds of complete benzodiazepine cessation among long-term users, providing a scalable, low-cost solution for

Mailed Self-Collection Kits: A Dual-Purpose Solution for Cervical Cancer and STI Screening in High-Risk Populations
newshealth equitypublic health

Mailed Self-Collection Kits: A Dual-Purpose Solution for Cervical Cancer and STI Screening in High-Risk Populations

By MedXY|Jan 15, 2026

A secondary analysis of the My Body, My Test-3 trial shows that mailed self-collection kits effectively detect both HPV and STIs in underscreened, low-income women, with high patient preference and significant clinical yield.

Weekly Semaglutide 2.4 mg Delivers 16% Weight Loss in Asian Adults with BMI ≥25: Results from the STEP 11 Phase 3 Trial
Diabetes & Endocrinologyobesitysemaglutide

Weekly Semaglutide 2.4 mg Delivers 16% Weight Loss in Asian Adults with BMI ≥25: Results from the STEP 11 Phase 3 Trial

By MedXY|Jan 15, 2026

The STEP 11 trial demonstrates that once-weekly semaglutide 2.4 mg significantly reduces bodyweight by 16% in Asian adults with obesity (BMI ≥25 kg/m2), providing robust evidence for population-specific clinical guidelines and reimbursement

Two-Dose HeV-sG-V Regimen Demonstrates Robust Neutralizing Antibody Response Against Nipah Virus in Phase 1 Trial
Infectious Diseasesimmunogenicityinfectious diseases

Two-Dose HeV-sG-V Regimen Demonstrates Robust Neutralizing Antibody Response Against Nipah Virus in Phase 1 Trial

By MedXY|Jan 14, 2026

A Phase 1 trial confirms that the HeV-sG-V vaccine is safe and, when administered in a two-dose 100 μg regimen, induces high levels of neutralizing antibodies against both Bangladesh and Malaysia strains of the Nipah virus.

A Breath of Protection: How a New Nasal Vaccine Could Stop Whooping Cough in its Tracks
Infectious DiseasesMucosal Immunity

A Breath of Protection: How a New Nasal Vaccine Could Stop Whooping Cough in its Tracks

By MedXY|Jan 13, 2026

A groundbreaking clinical trial reveals that a novel nasal vaccine, BPZE1, can prevent Bordetella pertussis colonization, offering a potential solution to the transmission gaps in current whooping cough immunization programs.

Dual-Purpose Public Health: Ivermectin Mass Drug Administration Reduces Malaria Incidence and Scabies Prevalence
Infectious Diseasesivermectinmalaria

Dual-Purpose Public Health: Ivermectin Mass Drug Administration Reduces Malaria Incidence and Scabies Prevalence

By MedXY|Jan 13, 2026

Large-scale trials in Kenya and Mozambique demonstrate that ivermectin mass drug administration significantly reduces malaria incidence by 26% and lowers community scabies prevalence, providing both direct protection and indirect herd-like

Does Green Medical Advice Compromise Patient Trust? Evidence from a Randomized Vignette Study
Family Medicine & NutritionPlanetary health

Does Green Medical Advice Compromise Patient Trust? Evidence from a Randomized Vignette Study

By MedXY|Jan 13, 2026

A Dutch randomized study reveals that explicitly advising sustainable treatment options can significantly decrease patient trust in high-severity clinical scenarios, highlighting a critical tension between planetary health goals and perceiv

Emodepside Challenges Ivermectin’s Dominance: Phase 2a Trial Reveals Highly Effective New Treatment for Strongyloidiasis
Infectious DiseasesNeglected tropical diseases

Emodepside Challenges Ivermectin’s Dominance: Phase 2a Trial Reveals Highly Effective New Treatment for Strongyloidiasis

By MedXY|Jan 13, 2026

A landmark phase 2a trial in Laos identifies emodepside as a highly effective, weight-independent treatment for Strongyloides stercoralis, achieving cure rates of 89% at a 15 mg dose, matching the current gold standard ivermectin with a rob

Prev
15 / 25
1…1314151617…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles